Tandem Diabetes Care (TNDM) Deferred Taxes (2013 - 2019)
Tandem Diabetes Care's (TNDM) quarterly Deferred Taxes came in at -$25000.0 in Q4 2019, up 62.85% quarter-over-quarter from -$67286.0 in Q1 2014.
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Deferred Taxes (2013 - 2019) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Deferred Taxes for 3 consecutive years, with -$25000.0 the latest figure, recorded in Q4 2019.
- For the quarter ending Q4 2019, Deferred Taxes changed N/A year-over-year to -$25000.0; the trailing twelve-month figure through Sep 2021 stood at -$25000.0 (up 72.91% YoY), and the FY2020 full-year result was -$2.1 million, down 8404.0% from the prior year.
- Deferred Taxes rose to -$25000.0 in Q4 2019 per TNDM's latest filing, from -$67286.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at -$25000.0 in Q4 2019 and bottomed at -$25000.0 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | -31.00 Mn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 127.00 Mn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 107.00 Mn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 17.00 Mn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | -181.30 Mn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | -300,000.00 |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 600,000.00 |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -25,000.00 |
| Mar 31, 2014 | -67,286.00 |
| Mar 31, 2013 | -141,137.00 |